Dmitry Zamoryakhin
Chief Tech/Sci/R&D Officer chez BIODEXA PHARMACEUTICALS PLC
Profil
Dmitry Zamoryakhin is currently the Chief Scientific Officer at Biodexa Pharmaceuticals Plc since 2021.
Prior to this, he worked as the Chief Medical Officer at Oxford Biomedica Plc from 2018 to 2021 and as the Head-Development Strategy & Intelligence at Grünenthal GmbH from 2016 to 2018.
Dr. Zamoryakhin holds an MBA and a doctorate from Warwick Business School and a doctorate from Perm State Medical University.
Postes actifs de Dmitry Zamoryakhin
| Sociétés | Poste | Début |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 11/07/2021 |
Anciens postes connus de Dmitry Zamoryakhin
| Sociétés | Poste | Fin |
|---|---|---|
| OXFORD BIOMEDICA PLC | Chief Tech/Sci/R&D Officer | 01/01/2021 |
Grünenthal GmbH
 Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Corporate Officer/Principal | 01/08/2018 |
Formation de Dmitry Zamoryakhin
| Warwick Business School | Doctorate Degree |
| Perm State Medical University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| OXFORD BIOMEDICA PLC | Health Technology |
| BIODEXA PHARMACEUTICALS PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Health Technology |
